Diabetes Mellitus (DM) represents one of the highest challenges in our century, due to the fact that in the last 20 years the number of patients with DM has doubled, at present affecting hundreds of millions of people worldwide, both in developed countries and in developing ones, as well. One of the most serious consequences of this increase is the onset of type 2 DM in children, adolescents and young people, the main causes being an unhealthy lifestyle: unhealthy food, lack of physical exercise, which, most of the times, lead to obesity. Also, DM is often associated to micro and macrovascular complications, thus determining disabilities and high costs in the healthcare systems, respectively. DM is one of the main causes of death all over the world, a reason for which there are required prevention programs worldwide.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. American Diabetes Association. Standards of Medical Care in Diabetes - 2015. Diabetes Care 38(Suppl1): S8-S16 2015.
2. Trăilescu A Șerban V. Diabetul zaharat: istoric și importanță. În: Tratat Român de Boli Metabolice. Șerban V (ed). Editura Brumar Timișoara pp 63-68 2010.
3. World Health Organization. The top 10 causes of death. Accesed on 1 feb 2016 at: http://www.who.int/mediacentre/factsheets/fs310/en/
4. International Diabetes Federation. IDF Diabetes Atlas – 7th Edition. Accesed on 1 feb 2016 at: https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf
5. Haffner SM Lehto S Rönnemaa T Pyörälä K Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229–234 1998.
6. Halanych JH Safford MM Keys WC et al. Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care 30: 2999–3004 2007.
7. Zimmet P Alberti KG Shaw J. Global and societal implications of the diabetes epidemic. Nature 414: 782–787 2001.
8. Joslin EP. The prevention of diabetes mellitus. JAMA 76: 79-84 1921.
9. Colagiuri S Borch-Johnsen K Glümer C Vistisen D. There really is an epidemic of type 2 diabetes. Diabetologia 48: 1459–1463 2005.
10. Wild S Roglic G Green A Sicree R King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–1053 2004.
11. Gregg EW Cadwell BL Cheng YJ et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 27: 2806–2812 2004.
12. Shaw JE Sicree RA Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4–14 2010.
13. Qiao Q Williams DE Imperatore G Narayan KM Tuomilehto J. Epidemiology and geography of type 2 diabetes mellitus. In: International Textbook of Diabetes Mellitus Fourth Edition. DeFronzo RA Ferrannini E Zimmet P Alberti G (eds). John Wiley & Sons Ltd Chichester UK pp 29-51 2015.
14. Soriguer F Goday A Bosch-Comas A et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 55: 88–93 2012.
15. Gardete-Correia L Boavida JM Raposo JF et al. First diabetes prevalence study in Portugal: PREVADIAB study. Diabet Med 27: 879–881 2010.
16. Green A Sortsø C Jensen PB Emneus M. Incidence morbidity mortality and prevalence of diabetes in Denmark 2000-2011: results from the Diabetes Impact Study 2013. Clin Epidemiol 7: 421–430 2015.
17. Jansson SP Fall K Brus O et al. Prevalence and incidence of diabetes mellitus: a nationwide population-based pharmaco-epidemiological study in Sweden. Diabet Med 32: 1319–1328 2015.
18. Heidemann C Du Y Paprott R Haftenberger M Rathmann W Scheidt-Nave C. Temporal changes in the prevalence of diagnosed diabetes undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997-1999 and 2008-2011. Diabet Med 2015. doi: 10.1111/dme.13008. [Epub ahead of print]
19. Huber CA Schwenkglenks M Rapold R Reich O. Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data 2006 and 2011. BMC Endocr Disord 14: 44 2014.
20. Satman I Omer B Tutuncu Y et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28: 169–180 2013.
21. Yeşilkaya E Cinaz P Andıran N et al. First report on the nationwide incidence and prevalence of Type 1 diabetes among children in Turkey. Diabet Med 2016. doi: 10.1111/dme.13063. [Epub ahead of print]
22. Monesi L Baviera M Marzona I et al. Prevalence incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study. Diabet Med 29: 385–392 2012.
23. Hamer M Kengne AP Batty GD Cooke D Stamatakis E. Temporal trends in diabetes prevalence and key diabetes risk factors in Scotland 2003-2008. Diabet Med 28: 595–598 2011.
24. Rutkowski M Bandosz P Czupryniak L et al. Prevalence of diabetes and impaired fasting glucose in Poland--the NATPOL 2011 Study. Diabet Med 31: 1568–1571 2014.
25. Saadi H Carruthers SG Nagelkerke N et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain United Arab Emirates. Diabetes Res Clin Pract 78: 369–377 2007.
26. Ng SW Zaghloul S Ali HI Harrison G Popkin BM. The prevalence and trends of overweight obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev 12: 1–13 2011.
27. Thorpe LE Upadhyay UD Chamany S et al. Prevalence and control of diabetes and impaired fasting glucose in New York City. Diabetes Care 32: 57–62 2009.
28. Cowie CC Rust KF Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 29: 1263–1268 2006.
29. Holman N Young B Gadsby R. What is the current prevalence of diagnosed and yet to be diagnosed diabetes in the UK. Diabet Med 31: 510–511 2014.
30. Karpati T Cohen-Stavi CJ Leibowitz M Hoshen M Feldman BS Balicer RD. Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel. Popul Health Metr 12: 32 2014.
31. Kalter-Leibovici O Chetrit A Lubin F et al. Adult-onset diabetes among Arabs and Jews in Israel: a population-based study. Diabet Med 29: 748–754 2012.
32. Moța M Popa SG Moța E et al. Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study. J. Diabetes 2015. doi: 10.1111/1753-0407.12297. [Epub ahead of print]
33. Ojuka EO Goyaram V. Increasing prevalence of type 2 diabetes in sub-Saharan Africa: not only a case of inadequate physical activity. Med Sport Sci 60: 27–35 2014.
34. Abebe SM Berhane Y Worku A Assefa A. Diabetes mellitus in North West Ethiopia: a community based study. BMC Public Health 14: 97 2014.
35. Zimmet PZ Magliano DJ Herman WH Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2: 56–64 2014.
36. Magliano DJ Söderberg S Zimmet PZ et al. Explaining the increase of diabetes prevalence and plasma glucose in Mauritius. Diabetes Care 35: 87–91 2012.
37. Bos M Agyemang C. Prevalence and complications of diabetes mellitus in Northern Africa a systematic review. BMC Public Health 13: 387 2013.
38. Menke A Casagrande S Geiss L Cowie CC. Prevalence of and Trends in Diabetes Among Adults in the United States 1988-2012. JAMA 314: 1021–1029 2015.
39. Dabelea D Mayer-Davis EJ Saydah S et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311: 1778–1786 2014.
40. Greiver M Williamson T Barber D et al. Prevalence and epidemiology of diabetes in Canadian primary care practices: a report from the Canadian Primary Care Sentinel Surveillance Network. Can J Diabetes 38: 179–185 2014.
41. de Almeida-Pititto B Dias ML de Moraes AC Ferreira SR Franco DR Eliaschewitz FG. Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab Syndr Obes 8: 17–28 2015.
42. Schellini SA Carvalho GM Rendeiro FS Padovani CR Hirai FE. Prevalence of diabetes and diabetic retinopathy in a Brazilian population. Ophthalmic Epidemiol 21: 33–38 2014.
43. Anjana RM Pradeepa R Deepa M et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 54: 3022–3027 2011.
44. Jan Mohamed HJ Yap RW Loy SL Norris SA Biesma R Aagaard-Hansen J. Prevalence and determinants of overweight obesity and type 2 diabetes mellitus in adults in Malaysia. Asia Pac J Public Health 27: 123–135 2015.
45. Pham NM Eggleston K. Prevalence and determinants of diabetes and prediabetes among Vietnamese adults. Diabetes Res Clin Pract 2016. doi: 10.1016/j.diabres.2015.12.009. [Epub ahead of print]
46. Gyawali B Sharma R Neupane D Mishra SR van Teijlingen E Kallestrup P. Prevalence of type 2 diabetes in Nepal: a systematic review and meta-analysis from 2000 to 2014. Glob Health Action 8: 29088 2015.
47. Chan JC Zhang Y Ning G. Diabetes in China: a societal solution for a personal challenge. Lancet Diabetes Endocrinol 2: 969–979 2014.
48. Xu Y Wang L He J et al. Prevalence and control of diabetes in Chinese adults. JAMA 310: 948–959 2013.
49. Khambalia A Phongsavan P Smith BJ et al. Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru. BMC Public Health 11: 719 2011.